Follow-up on outcomes after surgery with the LISA implant for back pain
Official title: LISA Post Market Clinical Follow-Up Study:Post Marketing Prospective Documentation of Clinical Outcomes (Post-operative, Safety and Performance) After Lumbar Dynamic Stabilization Surgery With LISA Implant
Run by Backbone · NCT04631133 · Data updated 2026-11-12
This study looks at how well the LISA implant works and its safety for people who have had surgery for chronic low-back pain.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 136 (estimated) |
| Sponsor | Backbone Industry-sponsored |
| Locations | 5 sites (Silkeborg and 4 other locations) |
| Status | Recruiting |
| Started | April 17, 2019 |
| Main results expected | December 31, 2024 |
| Study ends | December 31, 2028 |
| Registry record updated | July 21, 2022 |
| Trial ID | NCT04631133 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are skeletally mature adults aged 18 and older who have chronic low-back pain due to degenerative lesions and have not found relief from conservative treatments.
✕Probably not a fit
Patients with advanced degenerative disk lesions, spondylolisthesis, osteoporosis, or other specified exclusions may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study monitors the clinical outcomes of patients who have undergone surgery using the Lumbar Implant for Stiffness Augmentation (LISA) to treat chronic low-back pain associated with degenerative lesions. The LISA device, which has already received CE certification, consists of a PEEK interspinous spacer, a polyester band, and a titanium blocker, designed to stabilize the spine. The study aims to evaluate the long-term safety and performance of the LISA implant in a real-world setting following its market introduction.
Why it matters
Potential benefit: If successful, this study could provide valuable insights into the effectiveness and safety of the LISA implant, potentially improving treatment options for patients with chronic low-back pain.
How similar studies have gone: Other post-market studies of similar spinal implants have shown promising results, indicating that this approach is supported by prior successful evaluations.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Skeletally mature patients Patient ≥18 years of age * Patients with low-back pain caused by degenerative lesions of grade II, III and IV (Pfirrmann MRI classification) * Failed conservative treatment for low back pain conducted for at least 6 months Exclusion Criteria: * Stage V degenerative disk lesions in Pfirrmann's MRI classification * Spondylolisthesis * Osteoporosis * Non-specific back pain * Modic 2 and Modic 3 changes * L5/S1 segments affected * Local or general infections that may compromise the surgical goals * Major local inflammatory phenomena * Pregnant and lactating Women * Immunosuppressive diseases * Bone immaturity * Severe mental illnesses * Bone metabolism diseases that may compromise the mechanical support expected from this type of implant * Patient with worker's compensation, under litigation or on disability benefits * Excessive physical activities * Patients deprived of their liberty in accordance with respective national regulations * Protected patients or patients not in a position to declare his or her consent in accordance with respective national regulations
Where it's running
-
Elective Surgery Center, Silkeborg Regional Hospital
Silkeborg, Denmark Recruiting -
Pellegrin University Hospital Center
Bordeaux, France Recruiting -
Saint-Charles Clinic
Lyon, France Recruiting -
Pitié-Salpêtrière University Hospital Center
Paris, France Recruiting -
Asklepios Stadtklinik, Bad Wildungen
Bad Wildungen, Germany Recruiting
Study contacts
- Principal investigator: Vincent Pointillart — Pellegrin University Hospital Center
- Study coordinator: Aurélie Affret
- Email: aat@backbone.pro
- Phone: 0033686114973
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Minimally invasive artificial disc replacement for chronic low back pain
This study is testing a new device for replacing damaged discs in the lower back to see if it can help people with chronic back pain feel better without the downsides of traditional surgery.
-
Ultrasound-Guided Thoracolumbar Fascia Injection for Chronic Low Back Pain in Type 2 Diabetes
This trial tests whether an ultrasound-guided injection into the thoracolumbar fascia, added to standard care, helps reduce chronic low back pain in adults with type 2 diabetes.
-
Subcutaneous Fat, Back Muscles, and Spine Shape in Back Pain Patients
This study tests whether body fat under the skin and features of back muscles and spine joints are linked to lumbar facet joint degeneration in adults with chronic low back pain.
-
Long-Term safety and performance of the IntraSPINE interlaminar implant for degenerative lumbar spine disease
This study follows up patients who previously received IntraSPINE implants to see how their symptoms and imaging look about 9 years later.
-
See if serum BDNF levels relate to outcomes in chronic low back pain
This study tests whether blood BDNF levels can help predict how patients with chronic low back pain will do over time.
-
Correlating periostin levels with spinal degeneration in back pain
This study tests whether periostin levels in the intervertebral disc relate to the severity of disc degeneration in people with chronic low back pain and spinal stenosis.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.